Have a feature idea you'd love to see implemented?
Let us know!
CELU Celularity Inc
Price (delayed)
$2.35
Market cap
$51.66M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$7.85
Enterprise value
$105.78M
Highlights
The gross profit has soared by 152% since the previous quarter
CELU's revenue has soared by 110% year-on-year and by 47% since the previous quarter
The quick ratio has increased by 27% since the previous quarter but it has declined by 2.3% year-on-year
CELU's equity has dropped by 80% year-on-year and by 24% since the previous quarter
CELU's debt is up by 3.6% year-on-year
Key stats
What are the main financial stats of CELU
Market
Valuations
Earnings
Shares outstanding
21.98M
Market cap
$51.66M
Enterprise value
$105.78M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.46
Price to sales (P/S)
1.5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.16
Revenue
$33.52M
EBIT
-$150.4M
EBITDA
-$141.23M
Free cash flow
-$28.97M
Per share
Balance sheet
Liquidity
EPS
-$7.85
Free cash flow per share
-$1.35
Book value per share
$1.61
Revenue per share
$1.56
TBVPS
$5.88
Total assets
$143.82M
Total liabilities
$112.57M
Debt
$66.07M
Equity
$31.25M
Working capital
-$43.19M
Debt to equity
2.11
Current ratio
0.35
Quick ratio
0.42
Net debt/EBITDA
-0.38
Margins
Efficiency
Dividend
EBITDA margin
-421.4%
Gross margin
50.9%
Net margin
-460.3%
Operating margin
-660%
Return on assets
-89.3%
Return on equity
-279.3%
Return on invested capital
-133.5%
Return on capital employed
-193.4%
Return on sales
-448.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CELU stock price
How has the Celularity stock price performed over time
Intraday
9.58%
1 week
-15.47%
1 month
-18.4%
1 year
4.91%
YTD
-4.86%
QTD
-20.88%
Financial performance
How have Celularity's revenue and profit performed over time
Revenue
$33.52M
Gross profit
$17.06M
Operating income
-$221.2M
Net income
-$154.29M
Gross margin
50.9%
Net margin
-460.3%
The gross profit has soared by 152% since the previous quarter
CELU's revenue has soared by 110% year-on-year and by 47% since the previous quarter
The gross margin has surged by 71% since the previous quarter
Celularity's operating margin has increased by 49% QoQ and by 47% YoY
Growth
What is Celularity's growth rate over time
Valuation
What is Celularity stock price valuation
P/E
N/A
P/B
1.46
P/S
1.5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.16
Celularity's EPS has increased by 29% QoQ
CELU's equity has dropped by 80% year-on-year and by 24% since the previous quarter
The P/B is 22% less than the last 4 quarters average of 1.7
CELU's revenue has soared by 110% year-on-year and by 47% since the previous quarter
CELU's P/S is 90% below its 5-year quarterly average of 14.2 and 62% below its last 4 quarters average of 3.6
Efficiency
How efficient is Celularity business performance
Celularity's return on sales has increased by 47% QoQ
The return on equity has declined by 23% since the previous quarter
CELU's return on invested capital is up by 20% since the previous quarter
CELU's ROA is down by 3.5% since the previous quarter
Dividends
What is CELU's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CELU.
Financial health
How did Celularity financials performed over time
CELU's total assets is 28% greater than its total liabilities
CELU's total assets has dropped by 60% year-on-year
Celularity's total liabilities has decreased by 46% YoY but it has increased by 9% QoQ
CELU's debt is 111% greater than its equity
CELU's equity has dropped by 80% year-on-year and by 24% since the previous quarter
The debt to equity has grown by 32% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.